RG-6392

N/A

Report date: 2024/12/02 11:22:45
NME

Base Information

Drug NameRG-6392
Drug Alias NameRG-6392
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase receptor FLT3 stimulants
TargetsTyrosine-protein kinase receptor FLT3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesF.Hoffmann-La Roche Inc
China Registration ClassN/A

Develop Information

Active CompaniesF.Hoffmann-La Roche Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A